• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上海奥密克戎毒株流行期间老年重症新冠病毒感染的诊断模型

A diagnostic model for serious COVID-19 infection among older adults in Shanghai during the Omicron wave.

作者信息

Bao Suxia, Lu Guanzhu, Kang Yaoyue, Zhou Yuanyuan, Wang Yuhuan, Yan Lei, Yin Donglin, Bao Yujie, Yuan Xiaoling, Xu Jie

机构信息

Department of Infectious Disease, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Front Med (Lausanne). 2022 Dec 19;9:1018516. doi: 10.3389/fmed.2022.1018516. eCollection 2022.

DOI:10.3389/fmed.2022.1018516
PMID:36600892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9806114/
Abstract

BACKGROUND

The Omicron variant is characterized by striking infectivity and antibody evasion. The analysis of Omicron variant BA.2 infection risk factors is limited among geriatric individuals and understanding these risk factors would promote improvement in the public health system and reduction in mortality. Therefore, our research investigated BA.2 infection risk factors for discriminating severe/critical from mild/moderate geriatric patients.

METHODS

Baseline characteristics of enrolled geriatric patients (aged over 60 years) with Omicron infections were analyzed. A logistic regression analysis was conducted to evaluate factors correlated with severe/critical patients. A receiver operating characteristic (ROC) curve was constructed for predicting variables to discriminate mild/moderate patients from severe/critical patients.

RESULTS

A total of 595 geriatric patients older than 60 years were enrolled in this study. Lymphocyte subset levels were significantly decreased, and white blood cells (WBCs) and D-dimer levels were significantly increased with disease progression from a mild/moderate state to a severe/critical state. Univariate and multivariate logistic regression analyses identified a panel of WBCs, CD4 T cell, and D-dimer values that were correlated with good diagnostic accuracy for discriminating mild/moderate patients from severe/critical patients with an area under the curve of 0.962.

CONCLUSION

Some key baseline laboratory indicators change with disease development. A panel was identified for discriminating mild/moderate patients from severe/critical patients, suggesting that the panel could serve as a potential biomarker to enable physicians to provide timely medical services in clinical practice.

摘要

背景

奥密克戎变异株具有显著的传染性和抗体逃逸特性。在老年人群中,对奥密克戎变异株BA.2感染风险因素的分析有限,了解这些风险因素将有助于改善公共卫生系统并降低死亡率。因此,我们的研究调查了BA.2感染的风险因素,以区分老年患者的轻症/中症与重症/危重症。

方法

分析纳入的感染奥密克戎的老年患者(年龄超过60岁)的基线特征。进行逻辑回归分析以评估与重症/危重症患者相关的因素。构建受试者操作特征(ROC)曲线以预测区分轻症/中症患者与重症/危重症患者的变量。

结果

本研究共纳入595名60岁以上的老年患者。随着疾病从轻症/中症状态发展到重症/危重症状态,淋巴细胞亚群水平显著降低,白细胞(WBC)和D-二聚体水平显著升高。单因素和多因素逻辑回归分析确定了一组白细胞、CD4 T细胞和D-二聚体值,这些值对区分轻症/中症患者与重症/危重症患者具有良好的诊断准确性,曲线下面积为0.962。

结论

一些关键的基线实验室指标随疾病发展而变化。确定了一组区分轻症/中症患者与重症/危重症患者的指标,这表明该指标组可作为一种潜在的生物标志物,使医生能够在临床实践中提供及时的医疗服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f0/9806114/2c9a1166a075/fmed-09-1018516-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f0/9806114/6305c233a4ad/fmed-09-1018516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f0/9806114/56137e0257e9/fmed-09-1018516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f0/9806114/2c9a1166a075/fmed-09-1018516-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f0/9806114/6305c233a4ad/fmed-09-1018516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f0/9806114/56137e0257e9/fmed-09-1018516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f0/9806114/2c9a1166a075/fmed-09-1018516-g003.jpg

相似文献

1
A diagnostic model for serious COVID-19 infection among older adults in Shanghai during the Omicron wave.上海奥密克戎毒株流行期间老年重症新冠病毒感染的诊断模型
Front Med (Lausanne). 2022 Dec 19;9:1018516. doi: 10.3389/fmed.2022.1018516. eCollection 2022.
2
[Retrospective observation and analysis of autoimmune-related indicators in 317 patients with acute Omicron variant infection].317例急性奥密克戎变异株感染患者自身免疫相关指标的回顾性观察与分析
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jun;34(6):581-585. doi: 10.3760/cma.j.cn121430-20220418-00383.
3
Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave.上海奥密克戎变异株流行期间老年人发生严重 COVID-19 结局的老年风险和保护因素。
Emerg Microbes Infect. 2022 Dec;11(1):2045-2054. doi: 10.1080/22221751.2022.2109517.
4
The derived neutrophil to lymphocyte ratio can be the predictor of prognosis for COVID-19 Omicron BA.2 infected patients.衍生的中性粒细胞与淋巴细胞比值可预测 COVID-19 奥密克戎 BA.2 感染患者的预后。
Front Immunol. 2022 Nov 2;13:1065345. doi: 10.3389/fimmu.2022.1065345. eCollection 2022.
5
A study of clinical and serological correlation of early myocardial injury in elderly patients infected with the Omicron variant.奥密克戎变异株感染老年患者早期心肌损伤的临床与血清学相关性研究
Front Cardiovasc Med. 2024 Feb 14;11:1268499. doi: 10.3389/fcvm.2024.1268499. eCollection 2024.
6
Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.免疫、凝血和纤维蛋白溶解过程可能会降低 COVID-19 孕妇发生重症的风险。
Am J Obstet Gynecol. 2021 Apr;224(4):393.e1-393.e25. doi: 10.1016/j.ajog.2020.10.032. Epub 2020 Oct 22.
7
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.2022 年 2 月至 6 月上海奥密克戎 BA.2 引起的 COVID-19 疾病负担和临床严重程度的估计。
Emerg Microbes Infect. 2022 Dec;11(1):2800-2807. doi: 10.1080/22221751.2022.2128435.
8
Clinical characteristics and short-term mortality of 102 hospitalized hemodialysis patients infected with SARS-CoV-2 omicron BA.2.2.1 variant in Shanghai, China.中国上海102例感染新冠病毒奥密克戎BA.2.2.1变异株的住院血液透析患者的临床特征及短期死亡率
New Microbes New Infect. 2022 Nov-Dec;49:101058. doi: 10.1016/j.nmni.2022.101058. Epub 2022 Nov 25.
9
[Clinical analysis of severe/critical 2019 novel coronavirus Omicron variant infection combined with atrial fibrillation].[2019新型冠状病毒奥密克戎变异株重症/危重症感染合并心房颤动的临床分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Sep;34(9):900-904. doi: 10.3760/cma.j.cn121430-20220804-00712.
10
[Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].[新型冠状病毒肺炎重型/危重型患者临床特征分析及预警模型构建]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):401-406. doi: 10.3760/cma.j.cn121430-20200325-00410.

引用本文的文献

1
Random forest regression for prediction of Covid-19 daily cases and deaths in Turkey.用于预测土耳其新冠肺炎每日病例和死亡人数的随机森林回归分析
Heliyon. 2024 Feb 8;10(4):e25746. doi: 10.1016/j.heliyon.2024.e25746. eCollection 2024 Feb 29.
2
Distinguishing COVID-19 from seasonal influenza in patients under age 65 years-a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics.比较 2009 年甲型 H1N1 流感和 2022 年 SARS-CoV-2 大流行,对年龄<65 岁的患者进行回顾性观察队列研究,以区分 COVID-19 和季节性流感。
Front Cell Infect Microbiol. 2023 Jul 18;13:1179552. doi: 10.3389/fcimb.2023.1179552. eCollection 2023.
3

本文引用的文献

1
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages.SARS-CoV-2 奥密克戎 BA.1、BA.1.1、BA.2 和 BA.3 亚谱系的抗体逃逸。
Cell Host Microbe. 2022 Aug 10;30(8):1077-1083.e4. doi: 10.1016/j.chom.2022.05.001. Epub 2022 May 8.
2
Immune response of booster doses of BBIBP-CORV vaccines against the variants of concern of SARS-CoV-2.BBIBP-CORV 疫苗加强针针对 SARS-CoV-2 关切变异株的免疫应答。
J Clin Virol. 2022 Jun;150-151:105161. doi: 10.1016/j.jcv.2022.105161. Epub 2022 Apr 12.
3
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.
Prehospital physiological parameters related illness severity scores can accurately discriminate the severe/critical state in adult patients with COVID-19.
院前生理参数相关疾病严重程度评分可准确区分 COVID-19 成年患者的严重/危急状态。
Ann Med. 2023;55(2):2239829. doi: 10.1080/07853890.2023.2239829.
4
The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients.针对奥密克戎,小分子药物靶向 NSP1-核糖体复合物的抗病毒活性,特别是在老年患者中。
Front Cell Infect Microbiol. 2023 Mar 7;13:1141274. doi: 10.3389/fcimb.2023.1141274. eCollection 2023.
五种不同的新型冠状病毒2疫苗在病情缓解或疾病活动度低的自身免疫性风湿和肌肉骨骼疾病患者及健康对照中的体液和细胞免疫原性及安全性:一项单中心研究
Front Immunol. 2022 Mar 31;13:846248. doi: 10.3389/fimmu.2022.846248. eCollection 2022.
4
Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern.BBIBP-CorV 疫苗诱导的血清对 Beta、Delta 和其他关注的 SARS-CoV-2 变体的中和活性。
Nat Commun. 2022 Apr 4;13(1):1788. doi: 10.1038/s41467-022-29477-0.
5
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.奈玛特韦片/利托那韦片组合包装口服药用于伴有进展为重症高风险因素的 COVID-19 门诊患者。
N Engl J Med. 2022 Apr 14;386(15):1397-1408. doi: 10.1056/NEJMoa2118542. Epub 2022 Feb 16.
6
Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans.社论:比较 BBIBP-CorV(国药)和 BNT162b2(辉瑞-生物科技)疫苗在健康成年人群中针对 SARS-CoV-2 诱导的抗体和 T 细胞反应。
Geroscience. 2022 Feb;44(1):57-61. doi: 10.1007/s11357-021-00501-3. Epub 2021 Dec 21.
7
Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans.健康成年人中,BBIBP-CorV(国药)和 BNT162b2(辉瑞-生物科技)疫苗对 SARS-CoV-2 诱导的抗体和 T 细胞应答的比较。
Geroscience. 2021 Oct;43(5):2321-2331. doi: 10.1007/s11357-021-00471-6. Epub 2021 Oct 11.
8
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells.低剂量 mRNA-1273 COVID-19 疫苗可产生由交叉反应性 T 细胞增强的持久记忆。
Science. 2021 Oct 22;374(6566):eabj9853. doi: 10.1126/science.abj9853.
9
Activation or exhaustion of CD8 T cells in patients with COVID-19.COVID-19 患者 CD8 T 细胞的激活或耗竭。
Cell Mol Immunol. 2021 Oct;18(10):2325-2333. doi: 10.1038/s41423-021-00750-4. Epub 2021 Aug 19.
10
Impact of SARS-CoV-2 variants on the total CD4 and CD8 T cell reactivity in infected or vaccinated individuals.新冠病毒变异株对感染或接种个体中总 CD4 和 CD8 T 细胞反应性的影响。
Cell Rep Med. 2021 Jul 20;2(7):100355. doi: 10.1016/j.xcrm.2021.100355. Epub 2021 Jul 2.